Christopher Davitt
Christopher Davitt joined Farcast as Director of Partnerships and Commercial Strategy in the spring of 2024. He has over a decade of experience in immunology research, including preclinical and translational work in immuno-oncology, autoimmunity, inflammation, vaccines, microbiome, and infectious disease research. His expertise also extends to alliance management, business development, commercial and research strategy. Christopher is passionate about bringing together exceptional teams to collaboratively advance human health through cutting-edge therapies and diagnostics research and development. He holds both a B.A. and a Ph.D. from Trinity College Dublin, Ireland, and completed a postdoctoral fellowship at Tulane University School of Medicine in New Orleans before joining the biotech ecosystem in Boston.
-
24-Sep-2024Sierra BOpening Address & Keynote Presentation: Unlocking Tumor-Immune Dynamics: How TruTumor Histoculture Reveals Insights into Head and Neck Cancer Responses to Checkpoint Therapy
-
24-Sep-2024SonomaPreclinical models of the tumor microenvironment: translational value and derisking clinical trials
-
24-Sep-2024SonomaSponsor Led Poster Session: Preclinical models of the tumor microenvironment: translational value and derisking clinical trials